HRT and the heart: ERA of controversy continues

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1233, 2000-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin in acute stroke: the controversy continues

Inpharma, Vol. 1, Iss. 1377, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Controversy over ritonavir price hike continues

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 205-208

Informa Healthcare

Access to resources Recommend Favorite

Sodium Proton Exchanger Inhibitor in Ischemia/Reperfusion Injury in the Heart Surgery: Controversy in Clinical Application

Letters in Drug Design & Discovery, Vol. 4, Iss. 1, 2007-01 ,pp. : 9-14

Bentham Science Publishers

Access to resources Recommend Favorite

HRT out for the count?

Reactions Weekly, Vol. 1, Iss. 1149, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite